New coaching program helps cancer patients tackle nerve pain their way
NCT ID NCT06736600
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed pilot study tested a behavioral program called PIVOT in 33 adults with chemotherapy-induced peripheral neuropathy. Participants worked with coaches to set personal health goals using a structured goal-setting method. The study aimed to see if this approach is safe and feasible, as part of a larger effort to shift from disease-focused care to whole-person care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Goal-setting tele-coaching and Patient Priorities Care framework
- What this could lead to
- If successful, this approach could help patients manage chemotherapy-related nerve pain by focusing on what matters most to them.
- What could go wrong
- This is a small, early feasibility pilot with only 33 participants. It tests a behavioral intervention, not a drug, so benefits may be modest and not generalizable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
33 people
The number who actually took part.
- Started
-
Apr 2025
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Provision of signed and dated electronic informed consent form * Stated willingness to comply with all study procedures and availability for the duration of the study * Age 18 or older. * Documented diagnosis of chemotherapy-induced peripheral neuropathy meeting the following criteria: 1) onset associated with timing of neurotoxic chemotherapy and 2) symptomatic reports of peripheral neuropathy. * Access to smartphone and internet for participating in a technology-based intervention * Upcoming in-person appointment in the Main Hospital Pain Management Clinic 4-6 weeks from the consent date. * English-speaking * Pain or bothersome symptoms present most days of the week at an average of ≥4/10 on the Numeric Rating Scale for the past 3 months * No longer receiving cancer treatment or has been on stable maintenance treatment for the past 3 months. * Resides in the Houston Metroplex * A score ≤7 on the validated Six Item Cognitive Impairment Test (6CIT) for unimpaired cognition Exclusion Criteria: * Provision of signed and dated electronic informed consent form * Stated willingness to comply with all study procedures and availability for the duration of the study * Age 18 or older. * Documented diagnosis of chemotherapy-induced peripheral neuropathy meeting the following criteria: 1) onset associated with timing of neurotoxic chemotherapy and 2) symptomatic reports of peripheral neuropathy. * Access to smartphone and internet for participating in a technology-based intervention * Upcoming in-person appointment in the Main Hospital Pain Management Clinic 4-6 weeks from the consent date. * English-speaking * Pain or bothersome symptoms present most days of the week at an average of ≥4/10 on the Numeric Rating Scale for the past 3 months * No longer receiving cancer treatment or has been on stable maintenance treatment for the past 3 months. * Resides in the Houston Metroplex * A score ≤7 on the validated Six Item Cognitive Impairment Test (6CIT) for unimpaired cognition
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Peripheral neuropathy due to chemotherapy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New study aims to catch nerve damage early in chemo patients
- Patients help design device to stop chemo nerve damage
- Simple socks and gloves may shield cancer patients from Chemo's nerve pain
- Vitamin B12 trial aims to stop Chemo's painful side effect
- Fish oil may protect nerves during cancer treatment
- Could a chili pepper patch soothe chemo nerve pain?